Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Zibose-M 0.2 Tablet SR

Prescription Icon
Prescription Required

Marketer

FDC Ltd

Salt Composition

Metformin (500mg) + Voglibose (0.2mg)

Overview Zibose-M 0.2 Tablet SR

Metformin-based Zibos-M 0.2mg extended-release tablets are classified as anti-diabetic medications. This dual-action formulation treats type 2 diabetes in adults by regulating blood glucose. Administer this medication with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial; discontinuation without medical supervision risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, it's one component of a comprehensive diabetes management plan encompassing a balanced diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Possible side effects include nausea, altered taste perception, appetite suppression, gas, abdominal discomfort, diarrhea, and skin reactions. These are generally transient and self-limiting; however, persistent or concerning symptoms warrant medical attention. Your doctor can offer management strategies for bothersome side effects. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of cardiovascular disease should inform their physician before commencing treatment. Pregnant or lactating women must consult their doctor prior to use. Regular blood glucose monitoring is essential, and your doctor may order blood tests to track blood cell counts and liver health.

Primary Ingredients of Zibose-M 0.2 Tablet SR

No information provided. Please provide the text you wish me to rephrase.

Uses of Zibose-M 0.2 Tablet SR

Managing type 2 diabetes

Major Benefits of Zibose-M 0.2 Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Zibose-M 0.2 Tablet SR whole; do not crush, chew, or divide it. Administer this extended-release tablet with a meal.

Common Side effects of Zibose-M 0.2 Tablet SR:

  • Flatulence
  • Diarrhea
  • Abdominal pain
  • Vomiting
  • Decreased appetite

How to use Zibose-M 0.2 Tablet SR:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Zibose-M 0.2mg Extended-Release Tablet with a meal.

How Zibose-M 0.2 Tablet SR works:

Zibose-M 0.2 SR tablets contain a dual-action formulation for diabetes management.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Zibose-M 0.2 Tablet SR is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Zibose-M 0.2 Tablet SR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing this medication. Seek medical advice before using this drug.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The extended-release Zibose-M 0.2mg tablet is likely not safe for use while breastfeeding. Available human data indicate potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingSAFE

Driving ability is typically unaffected by Zibose-M 0.2 Tablet SR. Nevertheless, patients using this medication concurrently with other antidiabetic drugs, including sulfonylureas, insulin, and repaglinide, should be aware of the potential for low blood sugar.

KidneyKidneyCAUTION

Exercise caution when administering Zibose-M 0.2 Tablet SR to individuals with impaired renal function; dosage modification may be necessary. Consult a physician for guidance. Zibose-M 0.2 Tablet SR is contraindicated in patients exhibiting severe kidney disease. Routine monitoring of kidney function is recommended during treatment.

LiverLiverCONSULT YOUR DOCTOR

Insufficient data exists regarding Zibose-M 0.2 Tablet SR use in individuals with hepatic impairment. Physician consultation is advised.

What if you forget to take Zibose-M 0.2 Tablet SR :

Should you forget a dose of Zibose-M 0.2 Tablet SR, administer it at your earliest convenience. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Zibose-M 0.2 Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management
Zibose-M 0.2 Tablet SR
43
MRP 50
14% off